Intramuscular use of diphenylhydantoin
Baldwin, J.; Amerson, A.B.
American Journal of Hospital Pharmacy 30(9): 837-838
1973
ISSN/ISBN: 0002-9289 PMID: 4733637 Document Number: 60321
Document emailed within 1 workday
Related Documents
Al-Waili, N.S.; Saloom, K.Y. 1999: Intramuscular piroxicam versus intramuscular diclofenac sodium in the treatment of acute renal colic: double-blind study European Journal of Medical Research 4(1): 23-26Chu, J. 2000: Early observations in radiculopathic pain control using electrodiagnostically derived new treatment techniques: automated twitch-obtaining intramuscular stimulation (ATOIMS) and electrical twitch-obtaining intramuscular stimulation (ETOIMS) Electromyography and Clinical Neurophysiology 40(4): 195-204
Herishanu, Y.; Eylath, U. 1975: Diphenylhydantoin poisoning Harefuah 89(3): 110-111
Eadie, M.J.; Tyrer, J.H.; Hooper, W.D. 1973: Diphenylhydantoin dosage Proceedings of the Australian Association of Neurologists 10(0): 53-59
Sikic, B.I.; Baumel, I.P. 1976: The interaction of flurazepam with diphenylhydantoin in the rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 4(6): 584-586
Raz, S.; Zeigler, M.; Caine, M. 1973: The effect of diphenylhydantoin on the urethra Investigative Urology 10(4): 293-294
Giroud, M.; Fabre, J.L.; Brun, J.M.; Pelletier, J.L.; Touzery, C.; D'Athis, M.; Dumas, R. 1985: Effects of diphenylhydantoin on thyroid function Therapie 40(2): 119-122
Chebabo, S.R.; Do-Carmo, R.J.; Martins-Ferreira, H. 1988: The effect of diphenylhydantoin on spreading depression Brazilian Journal of Medical and Biological Research 21(3): 603-605
Sepúlveda Vildósola, A.C.; López Aguilar, E.; Yáñez López, P.; Ramírez Colorado, R.; Escobar Padilla, B.; Madrazo De la Garza, A. 1999: Sodium diphenylhydantoin as a probable cause of pancreatitis Revista de Gastroenterologia de Mexico 64(4): 186-189
Lomanto, B.; Lotto, A.; Cavallaro, G.F. 1973: Indications of diphenylhydantoin in cardiac arrhythmias Bollettino Della Societa Italiana di Cardiologia 18(1): 3-11
Ohkawa, T.; Ohno, M.; Fujioka, H.; Fujii, J.; Maeda, J.; Ueki, N.; Tamura, S.; Hada, T.; Higashino, K.; Nakasho, K. 1991: A case of diphenylhydantoin-induced pneumonitis Nihon Kyobu Shikkan Gakkai Zasshi 29(11): 1469-1473
Koren, G.; Frand, M.; Barzilay, Z.; Brand, N. 1980: Failure of diphenylhydantoin treatment in children Harefuah 99(1-2): 33-34
Vogel, M.; Motté, G. 1975: Indications and surveillance of lignocaine and diphenylhydantoin treatments La Revue du Praticien 25(45): 3499-3500; 3503-6; 3509-3510 Passim
Rusia, U.; Malhotra, P.; Joshi, P. 2006: Diphenylhydantoin-induced pure red cell aplasia Journal of the Indian Medical Association 104(1): 34-36
Ceppi, J.A.; Zaninovich, A.A. 1986: Effects of diphenylhydantoin on intrapituitary conversion of T4 to T3 in rats Medicina 46(4): 418-422
Kooiker, J.C.; Sumi, S.M. 1974: Movement disorder as a manifestation of diphenylhydantoin intoxication Neurology 24(1): 68-71
Kaufmann, G. 1974: The place of diphenylhydantoin in the practice of heart therapy Therapeutische Umschau. Revue Therapeutique 31(2): 78-83
Murphy, M.J.; Goldstein, M.N. 1974: Diphenylhydantoin-induced asterixis. a clinical study JAMA 229(5): 538-540
Sohn, R.S.; Ferrendelli, J.A. 1973: Inhibition of Ca ++ transport into rat brain synaptosomes by diphenylhydantoin (DPH) Journal of Pharmacology and Experimental Therapeutics 185(2): 272-275
Ziegler, D.K. 1978: Toxicity to the nervous system of diphenylhydantoin: a review International Journal of Neurology 11(4): 383-400